• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Generation of CAR T-cells using γ-retroviral vector.使用γ-逆转录病毒载体生成嵌合抗原受体(CAR)T细胞。
Methods Cell Biol. 2022;167:171-183. doi: 10.1016/bs.mcb.2021.06.014. Epub 2021 Jul 30.
2
Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors.使用γ逆转录病毒载体生成嵌合抗原受体T细胞。
Methods Mol Biol. 2020;2086:119-130. doi: 10.1007/978-1-0716-0146-4_8.
3
Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.无细菌微环 DNA 系统生成无整合 CAR-T 细胞。
J Med Genet. 2019 Jan;56(1):10-17. doi: 10.1136/jmedgenet-2018-105405. Epub 2018 Jul 20.
4
Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene.携带抗 Her2 嵌合抗原受体基因的重组慢病毒生产方案的比较分析与优化。
J Gene Med. 2018 Jul;20(7-8):e3027. doi: 10.1002/jgm.3027. Epub 2018 Jul 6.
5
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.逆转录病毒修饰的嵌合抗原受体 T 细胞的十年安全性和功能。
Sci Transl Med. 2012 May 2;4(132):132ra53. doi: 10.1126/scitranslmed.3003761.
6
Expansion and Retroviral Transduction of Primary Murine T Cells for CAR T-Cell Therapy.原代鼠 T 细胞的扩增和逆转录病毒转导用于 CAR T 细胞治疗。
Methods Mol Biol. 2024;2748:41-53. doi: 10.1007/978-1-0716-3593-3_4.
7
TCR and CAR Engineering of Primary Human T Cells.T 细胞受体和嵌合抗原受体工程改造原代人 T 细胞。
Methods Mol Biol. 2022;2521:85-93. doi: 10.1007/978-1-0716-2441-8_5.
8
Optimized Production of Lentiviral Vectors for CAR-T Cell.用于CAR-T细胞的慢病毒载体的优化生产
Methods Mol Biol. 2020;2086:69-76. doi: 10.1007/978-1-0716-0146-4_5.
9
A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.一种逆转录病毒载体系统“STITCH”与优化的单链抗体嵌合受体基因结构相结合,可使人T淋巴细胞实现高效的基因转导和表达。
Gene Ther. 1998 Sep;5(9):1195-203. doi: 10.1038/sj.gt.3300696.
10
Generation of CAR-T cells using lentiviral vectors.使用慢病毒载体生成 CAR-T 细胞。
Methods Cell Biol. 2022;167:39-69. doi: 10.1016/bs.mcb.2021.07.001. Epub 2021 Sep 15.

引用本文的文献

1
Emerging CAR immunotherapies: broadening therapeutic horizons beyond cancer.新兴的嵌合抗原受体免疫疗法:拓展癌症以外的治疗视野。
Clin Exp Med. 2025 Aug 4;25(1):274. doi: 10.1007/s10238-025-01820-x.
2
Cost-effective strategies for CAR-T cell therapy manufacturing.嵌合抗原受体T细胞(CAR-T)疗法生产的经济高效策略。
Mol Ther Oncol. 2025 Apr 3;33(2):200980. doi: 10.1016/j.omton.2025.200980. eCollection 2025 Jun 18.
3
Strategies for Altering Delivery Technologies to Optimize CAR Therapy.改变递送技术以优化嵌合抗原受体(CAR)疗法的策略。
Int J Mol Sci. 2025 Mar 30;26(7):3206. doi: 10.3390/ijms26073206.
4
functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma.表达赖氨酸特异性去甲基化酶1短发夹RNA的抗CD19嵌合抗原受体T细胞治疗弥漫性大B细胞淋巴瘤的功能验证
Front Immunol. 2025 Jan 13;15:1521778. doi: 10.3389/fimmu.2024.1521778. eCollection 2024.
5
The design of retroviral vectors used in the CAR-T products, risk management, and future perspective.嵌合抗原受体T细胞(CAR-T)产品中使用的逆转录病毒载体设计、风险管理及未来展望。
MedComm (2020). 2025 Jan 24;6(2):e70067. doi: 10.1002/mco2.70067. eCollection 2025 Feb.
6
Metabolic priming of GD2 -CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence.在制造过程中对GD2嵌合抗原受体T细胞进行代谢预处理可促进记忆表型,同时增强其持久性。
Mol Ther Methods Clin Dev. 2024 Apr 10;32(2):101249. doi: 10.1016/j.omtm.2024.101249. eCollection 2024 Jun 13.
7
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis.人血小板裂解物通过减少细胞衰老和凋亡来增强 CAR-Vδ2 T 细胞的体内活性。
Cytotherapy. 2024 Aug;26(8):858-868. doi: 10.1016/j.jcyt.2024.03.006. Epub 2024 Mar 12.
8
Advances in CAR-Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies.嵌合抗原受体工程免疫细胞的进展:工程方法和来源策略。
Adv Sci (Weinh). 2023 Dec;10(35):e2303215. doi: 10.1002/advs.202303215. Epub 2023 Oct 31.
9
Impact of Manufacturing Procedures on CAR T Cell Functionality.制造工艺对 CAR T 细胞功能的影响。
Front Immunol. 2022 Apr 13;13:876339. doi: 10.3389/fimmu.2022.876339. eCollection 2022.

本文引用的文献

1
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.急性淋巴细胞白血病中CD19嵌合抗原受体疗法的长期随访
N Engl J Med. 2018 Feb 1;378(5):449-459. doi: 10.1056/NEJMoa1709919.
2
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.替沙格赛定用于治疗儿童和年轻成人B细胞淋巴细胞白血病
N Engl J Med. 2018 Feb 1;378(5):439-448. doi: 10.1056/NEJMoa1709866.
3
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.嵌合抗原受体中 4-1BB 共刺激会阻碍 T 细胞存活,且具有载体依赖性。
Cell Rep. 2017 Oct 3;21(1):17-26. doi: 10.1016/j.celrep.2017.09.015.
4
Genetic Modification of T Cells.T细胞的基因改造
Biomedicines. 2016 Apr 20;4(2):9. doi: 10.3390/biomedicines4020009.
5
Clinical manufacturing of CAR T cells: foundation of a promising therapy.CAR T 细胞的临床生产:一种有前途的治疗方法的基础。
Mol Ther Oncolytics. 2016 Jun 15;3:16015. doi: 10.1038/mto.2016.15. eCollection 2016.
6
Toxicities of chimeric antigen receptor T cells: recognition and management.嵌合抗原受体T细胞的毒性:识别与管理
Blood. 2016 Jun 30;127(26):3321-30. doi: 10.1182/blood-2016-04-703751. Epub 2016 May 20.
7
Non-viral vectors for gene-based therapy.基于基因治疗的非病毒载体。
Nat Rev Genet. 2014 Aug;15(8):541-55. doi: 10.1038/nrg3763. Epub 2014 Jul 15.
8
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.间皮素特异性嵌合抗原受体 mRNA 修饰 T 细胞在实体恶性肿瘤中诱导抗肿瘤活性。
Cancer Immunol Res. 2014 Feb;2(2):112-20. doi: 10.1158/2326-6066.CIR-13-0170.
9
Gammaretroviral vectors: biology, technology and application.γ 逆转录病毒载体:生物学、技术与应用。
Viruses. 2011 Jun;3(6):677-713. doi: 10.3390/v3060677. Epub 2011 Jun 3.
10
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.基于 EBV 特异性细胞毒性 T 细胞的嵌合抗原受体表达的猪源转座酶介导的癌症免疫疗法,该受体针对 HER2 。
Mol Ther. 2011 Dec;19(12):2133-43. doi: 10.1038/mt.2011.131. Epub 2011 Jul 19.

使用γ-逆转录病毒载体生成嵌合抗原受体(CAR)T细胞。

Generation of CAR T-cells using γ-retroviral vector.

作者信息

Watanabe Norihiro, McKenna Mary Kathryn

机构信息

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, United States.

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, United States.

出版信息

Methods Cell Biol. 2022;167:171-183. doi: 10.1016/bs.mcb.2021.06.014. Epub 2021 Jul 30.

DOI:10.1016/bs.mcb.2021.06.014
PMID:35152995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8917789/
Abstract

The generation of chimeric antigen receptor (CAR) T cells requires the transfer of the CAR gene into primary T cells. Among various gene transfer strategies, gammaretroviral vectors have been widely used to generate CAR T cells for both preclinical and clinical settings. Here we describe the detailed method of generating CAR T cells utilizing gammaretroviral vectors. This approach consists of two parallel parts: (1) production of the gammaretroviral particles and (2) gammaretroviral transduction of activated T cells. The gammaretroviral particles are produced by co-transfecting the gammaretroviral vector with packaging plasmids into 293T cells. The manufactured viral particles then efficiently infect activated T cells where the CAR transgene is integrated into host genomic DNA, resulting in stable expression of the CAR molecule on the surface of T cells.

摘要

嵌合抗原受体(CAR)T细胞的产生需要将CAR基因转移到原代T细胞中。在各种基因转移策略中,γ逆转录病毒载体已被广泛用于在临床前和临床环境中产生CAR T细胞。在这里,我们描述了利用γ逆转录病毒载体产生CAR T细胞的详细方法。该方法包括两个并行部分:(1)γ逆转录病毒颗粒的生产和(2)活化T细胞的γ逆转录病毒转导。γ逆转录病毒颗粒是通过将γ逆转录病毒载体与包装质粒共转染到293T细胞中产生的。然后,制造的病毒颗粒有效地感染活化的T细胞,其中CAR转基因整合到宿主基因组DNA中,导致CAR分子在T细胞表面稳定表达。